A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Clinical trial NCT07304089 · RECRUITING
Trial details
- NCT number
- NCT07304089
- Sponsor
- Vima Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-05
- Primary completion
- 2027-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.